Celebrating 40 years as a charitable nonprofit, Prader-Willi Syndrome Association (USA) [“PWSA (USA)”] is pleased to offer grant assistance for scientific researchers with an interest in improving the lives of those with Prader-Willi syndrome (PWS). PWSA (USA) is seeking to fund projects for a maximum of $75,000 total per project for a 1-2 year grant support aimed at discovering and developing treatments, cures and technologies benefiting those with Prader-Willi syndrome.
pwsaView posts by pwsa
FDA Advisory Committee to Review LEVO’s Carbetocin as a Treatment for PWS
September 10, 2021
Soleno Therapeutics Announces Positive Data Showing Continued Significant Improvements in Symptoms of PWS following One Year Treatment with DCCR
September 9, 2021
A Message from PWSA | USA’s CEO Paige Rivard Regarding Dr. van Bosse
September 1, 2021